Identification of early stage and metastatic prostate cancer using electrochemical detection of beta-2-microglobulin in urine samples from patients

Autor: Hashmatullah Nasimi, Jonna Skov Madsen, Ahmed H. Zedan, Anders Malmendal, Palle Jörn Sloth Osther, Fatima AlZahra’a Alatraktchi

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract To improve prostate cancer (PCa) diagnosis, it is imperative to identify novel biomarkers and establish effective screening techniques. Here, we introduce electrochemical biosensing of β-2-Microglobulin (β2M) in urine as a potential diagno

Externí odkaz: https://doaj.org/article/382029c0d66d489d9294313ab9a546d0

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

Autor: Torben Frøstrup Hansen, Line Nederby, Ahmed H. Zedan, Inge Mejlholm, Jon R. Henriksen, Karina D. Steffensen, Caroline B. Thomsen, Louise Raunkilde, Lars Henrik Jensen, Anders Jakobsen

Publikováno v: Translational Oncology, Vol 12, Iss 7, Pp 968-972 (2019)

INTRODUCTION: The aim of the present study was to analyze the possible correlation between Natural Killer (NK) cell activity as measured by the NK Vue assay and treatment efficacy in patients with disseminated cancer. MATERIALS AND METHODS: The study

Externí odkaz: https://doaj.org/article/addddd0d570e43a1a92a4b84f831cd0d

Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically

Autor: Hashmatullah Nasimi, Jonna Skov Madsen, Ahmed H. Zedan, Anne Vibeke Schmedes, Anders Malmendal, Palle Jörn Sloth Osther, Fatima AlZahra'a Alatraktchi

Publikováno v: Nasimi, H, Madsen, J S, Zedan, A H, Schmedes, A V, Malmendal, A, Osther, P J S & Alatraktchi, F A Z A 2022, ' Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically ', Analytical Biochemistry, vol. 649, 114698 . https://doi.org/10.1016/j.ab.2022.114698

Prostate cancer (PCa) is the second most common cancer in men and one of the leading causes of cancer-related deaths. Early detection is the key to successful treatment and provides the greatest chance to cure the patient. Currently, early detection

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7d85991c48fa79aac4e7c95ff77b7e
https://findresearcher.sdu.dk:8443/ws/files/202522887/1_s2.0_S0003269722001543_main.pdf